These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33141164)

  • 21. Risk factors for severe acute respiratory syndrome coronavirus 2 infection in pregnant women.
    Sakowicz A; Ayala AE; Ukeje CC; Witting CS; Grobman WA; Miller ES
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100198. PubMed ID: 32838274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco.
    Chamie G; Marquez C; Crawford E; Peng J; Petersen M; Schwab D; Schwab J; Martinez J; Jones D; Black D; Gandhi M; Kerkhoff AD; Jain V; Sergi F; Jacobo J; Rojas S; Tulier-Laiwa V; Gallardo-Brown T; Appa A; Chiu C; Rodgers M; Hackett J; ; Kistler A; Hao S; Kamm J; Dynerman D; Batson J; Greenhouse B; DeRisi J; Havlir DV
    Clin Infect Dis; 2021 Jul; 73(Suppl 2):S127-S135. PubMed ID: 32821935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged <18 Years in an Outpatient Pediatric Practice - Metropolitan Atlanta, Georgia, May-December 2020.
    Miller MJ; Dasgupta S; Ruffin J; Colton K; King D; Tate JE; Kirking HL; Bryant B; Hennesy N; Plata Z; Nakayama JY; Tanner MR; Koyuncu A; Rabold E
    J Adolesc Health; 2021 Jul; 69(1):144-148. PubMed ID: 34172138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.
    Lin A; He ZB; Zhang S; Zhang JG; Zhang X; Yan WH
    Clin Infect Dis; 2020 Nov; 71(16):2061-2065. PubMed ID: 32337591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infection, 22 US States and DC, January 1-October 1, 2020.
    Hollis ND; Li W; Van Dyke ME; Njie GJ; Scobie HM; Parker EM; Penman-Aguilar A; Clarke KEN
    Emerg Infect Dis; 2021; 27(5):1477-1481. PubMed ID: 33900192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit.
    Naqvi M; Burwick RM; Ozimek JA; Greene NH; Kilpatrick SJ; Wong MS
    Obstet Gynecol; 2020 Aug; 136(2):235-236. PubMed ID: 32433450
    [No Abstract]   [Full Text] [Related]  

  • 27. SARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors.
    Haque R; Chen L
    JCO Clin Cancer Inform; 2021 Feb; 5():168-175. PubMed ID: 33539175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
    Lalwani P; Salgado BB; Filho IVP; da Silva DSS; de Morais TBDN; Jordão MF; Barbosa ARC; Cordeiro IB; Neto JNS; de Assunção EN; Dos Santos RO; Carvalho NO; Sobrinho WBS; da Costa CF; de Souza PE; de Albuquerque BC; Ganoza CA; Araujo-Castillo RV; Filho SA; Lalwani JDB;
    Int J Infect Dis; 2021 Sep; 110():141-150. PubMed ID: 34273518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.
    Angelidou A; Sullivan K; Melvin PR; Shui JE; Goldfarb IT; Bartolome R; Chaudhary N; Vaidya R; Culic I; Singh R; Yanni D; Patrizi S; Hudak ML; Parker MG; Belfort MB
    JAMA Netw Open; 2021 Apr; 4(4):e217523. PubMed ID: 33890989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community Testing and SARS-CoV-2 Rates for Latinxs in Baltimore.
    Bigelow BF; Saxton RE; Flores-Miller A; Mostafa HH; Loss MJ; Phillips KH; Moore AM; Hale WD; Tolson TM; McCann NS; Catlett CL; Golden SH; Clark JM; Page KR
    Am J Prev Med; 2021 Jun; 60(6):e281-e286. PubMed ID: 33775510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Adhikari EH; Moreno W; Zofkie AC; MacDonald L; McIntire DD; Collins RRJ; Spong CY
    JAMA Netw Open; 2020 Nov; 3(11):e2029256. PubMed ID: 33211113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus Disease 2019 (COVID-19) Infections Among Healthcare Workers, Los Angeles County, February-May 2020.
    Hartmann S; Rubin Z; Sato H; O Yong K; Terashita D; Balter S
    Clin Infect Dis; 2021 Oct; 73(7):e1850-e1854. PubMed ID: 32803237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of socioeconomic differences in COVID-19 screening and hospitalizations.
    Dalton JE; Gunzler DD; Jain V; Perzynski AT; Dawson NV; Einstadter D; Tarabichi Y; Imrey PB; Lewis M; Kattan MW; Yao J; Taksler G; Berg KA; Krieger NI; Kaelber D; Jehi L; Kalra A
    PLoS One; 2021; 16(8):e0255343. PubMed ID: 34351971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020.
    Spellberg B; Haddix M; Lee R; Butler-Wu S; Holtom P; Yee H; Gounder P
    JAMA; 2020 May; 323(19):1966-1967. PubMed ID: 32232421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of SARS-CoV-2 Positivity Based on RT-PCR Swab Tests at a Drive-Through Outpatient Clinic for COVID-19 Screening in Japan.
    Ishii T; Kushimoto S; Katori Y; Kure S; Igarashi K; Fujita M; Takayama S; Abe M; Tanaka J; Kikuchi A; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Akaishi T
    Tohoku J Exp Med; 2021 Feb; 253(2):101-108. PubMed ID: 33536379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Neighborhood-Level Factors and COVID-19 Infection Patterns in Philadelphia Using Spatial Regression.
    Boland MR; Liu J; Balocchi C; Meeker J; Bai R; Mellis I; Mowery DL; Herman D
    AMIA Jt Summits Transl Sci Proc; 2021; 2021():545-554. PubMed ID: 34457170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Bayesian Spatial-Temporal Approach to Quantify SARS-CoV-2 Testing Disparities for Small Area Estimation.
    Bauer C; Li X; Zhang K; Lee M; Guajardo E; Fisher-Hoch S; McCormick J; Fernandez ME; Reininger B
    Am J Public Health; 2023 Jan; 113(1):40-48. PubMed ID: 36516388
    [No Abstract]   [Full Text] [Related]  

  • 38. County-Level Determinants of COVID-19 Testing and Cases: Are There Racial/Ethnic Disparities in Texas?
    Adepoju OE; Ojinnaka CO
    Popul Health Manag; 2021 Oct; 24(5):589-594. PubMed ID: 33544028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential impacts of COVID-19 mortality on mental health by residential geographic regions: The Los Angeles Pandemic Surveillance Cohort Study.
    Lam CN; Lee R; Soto D; Ho A; Nicholas W; Unger JB; Sood N
    PLoS One; 2024; 19(7):e0304779. PubMed ID: 38980887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tale of Two Institutions: COVID-19 Positive Rates in Asymptomatic Patients Pre-Screened for Spine Procedures and Surgeries in Los Angeles, California.
    Chen AS; Brown M; Arekelyan A; Wennemann S; Shamie N; Holly L; Liu JC; Wang JC; Buser Z
    Global Spine J; 2023 Sep; 13(7):1865-1870. PubMed ID: 34870486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.